Description:
ROTHMUND-THOMSON SYNDROME; RTS
RECQ PROTEIN-LIKE 4; RECQL4
|
Repository
|
NIA Aging Cell Culture Repository
|
| Subcollection |
Heritable Diseases |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
Hispanic/Latino
|
|
Family Member
|
2
|
|
Relation to Proband
|
mother
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
ISCN
|
47,XX,+18[14]/46,XX[36]
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
7 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Gene |
RECQL4 |
| Chromosomal Location |
8q24.3 |
| Allelic Variant 1 |
GLN810TER; ROTHMUND-THOMSON SYNDROME |
| Identified Mutation |
g.4503C>T |
| Remarks |
Clinically unaffected; donor is mother of AG18465 (LCL); the donor subject is heterozygous for a truncating mutation in the RECQL4 gene: a C>T transition at nucleotide g.4503(g.4503C>T) in exon 14 which leads to truncation at codon 810 [GLN810TER (Q810X)]. The karyotype is 47,XX,+18[14]/46,XX[36] with 12% of the cells examined showing random chromosome loss/gain. It is thought that the trisomy 18 arose during culturing. The legacy karyotype description shown in this Remark may not be representative of the current available product. |
| Passage Frozen |
7 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
MEM (Eagle) Alpha Modification with nucleosides with 2mM L-glutamine or equivalent |
| Serum |
10% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|